SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-010347
Filing Date
2015-02-13
Accepted
2015-02-13 16:01:47
Documents
2
Period of Report
2015-02-13

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5176
2 EX-24.1 ex-24d1.htm EX-24.1 11333
  Complete submission text file 0001104659-15-010347.txt   17910
Mailing Address C/O IKARIA, INC. 6 STATE ROUTE 173 CLINTON NJ 08809
Business Address
Tasse Daniel (Reporting) CIK: 0001502785 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36845 | Film No.: 15614144

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations